These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15726304)

  • 1. [Antitumour vaccination in patients with ENT tumours. Successful track record].
    Dyckhoff G; Herold-Mende C
    HNO; 2005 Mar; 53(3):209-12. PubMed ID: 15726304
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic vaccination for cancer immunotherapy: antigen selection and clinical responses.
    Geldmacher A; Freier A; Losch FO; Walden P
    Hum Vaccin; 2011; 7 Suppl():115-9. PubMed ID: 21245666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of surgical malignancies.
    Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
    Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
    [No Abstract]   [Full Text] [Related]  

  • 4. A new twist on autologous cancer vaccines.
    Emens LA
    Cancer Biol Ther; 2003; 2(2):161-3. PubMed ID: 12750555
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cancer specific antigen, glypican-3 (GPC3)-targeted immunotherapy].
    Sawada Y; Nakatsura T
    Nihon Rinsho; 2012 Dec; 70(12):2136-41. PubMed ID: 23259386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unfulfilled promise of melanoma vaccines.
    Livingston P
    Clin Cancer Res; 2001 Jul; 7(7):1837-8. PubMed ID: 11448892
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccines: what do we need to measure in clinical trials?
    Kudrin A
    Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma vaccines: achievements and perspectives.
    Brichard VG; Gérard C
    Forum (Genova); 2003; 13(2):144-54; quiz 189. PubMed ID: 14732881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune therapy for ovarian cancer: promise and pitfalls.
    Thibodeaux SR; Curiel TJ
    Int Rev Immunol; 2011; 30(2-3):102-19. PubMed ID: 21557637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines in leukemia.
    Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
    Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential targets for pancreatic cancer immunotherapeutics.
    Dodson LF; Hawkins WG; Goedegebuure P
    Immunotherapy; 2011 Apr; 3(4):517-37. PubMed ID: 21463193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ vaccination as a therapy for low-grade lymphoma.
    Brody J
    Clin Adv Hematol Oncol; 2015 Jan; 13(1):26-8. PubMed ID: 25679970
    [No Abstract]   [Full Text] [Related]  

  • 15. Peptide vaccines for patients with acute myeloid leukemia.
    Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
    Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy Against Head and Neck Cancer Stem Cells].
    Coordes A; Ochsenreither S; Qian X; Hofmann VM; Meyer JE; Karl Hoffmann T; Kaufmann AM; Albers AE
    Laryngorhinootologie; 2017 Apr; 96(4):216-224. PubMed ID: 28493252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
    Shurin MR; Gregory M; Morris JC; Malyguine AM
    Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Q&A: Evidence presenter. Interview by Marian Turner.
    Palucka K
    Nature; 2013 Dec; 504(7480):S9. PubMed ID: 24352364
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing immunogenicity of cancer vaccines to improve their clinical outcome.
    Parmiani G; Cimminiello C; Maccalli C
    Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.